Global Epidemiology of Hepatocellular Carcinoma

Ferlay J, Parkin DM, Curado MP, et al. Cancer incidence in five continents, volumes I to X: IARC CANCERBase No. 10 [Internet]. 2014. Available at: http://ci5.iarc.fr. Accessed November 25, 2014.

Ferlay J, Soerjomataram I, Ervik M, et al. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. Lyon (France): International Agency for Research on Cancer. 2013. Available at: http://globocan.iarc.fr. Accessed November 12, 2014.

Altekruse, 2014, Changing hepatocellular carcinoma incidence and liver cancer mortality rates in the United States, Am J Gastroenterol, 109, 542, 10.1038/ajg.2014.11

Gao, 2012, Declining rates of hepatocellular carcinoma in urban Shanghai: incidence trends in 1976-2005, Eur J Epidemiol, 27, 39, 10.1007/s10654-011-9636-8

Tanaka, 2008, Declining incidence of hepatocellular carcinoma in Osaka, Japan, from 1990 to 2003, Ann Intern Med, 148, 820, 10.7326/0003-4819-148-11-200806030-00004

Surveillance, Epidemiology, and End Results (SEER) Program (www.seer.cancer.gov) SEER*Stat Database: Incidence - SEER 18 Regs Research Data + Hurricane Katrina Impacted Louisiana Cases, Nov 2013 Sub (1973–2011) Total U.S., National Cancer Institute, DCCPS, Surveillance Research Program, Surveillance Systems Branch, based on the November 2013 submission. 2014.

Surveillance, Epidemiology and End Results (SEER) Program. SEER*Stat Database: North American Association of Central Cancer Registries (NAACCR) Incidence-CiNA Analytic File, 1995–2009. Bethesda, MD: National Cancer Institute, Division of Cancer Control and Population Sciences, Surveillance Research Program, Surveillance Systems Branch. 2012.

Perz, 2006, The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide, J Hepatol, 45, 529, 10.1016/j.jhep.2006.05.013

Paraskevis, 2013, Dating the origin and dispersal of hepatitis B virus infection in humans and primates, Hepatology, 57, 908, 10.1002/hep.26079

Simmonds, 2001, Reconstructing the origins of human hepatitis viruses, Philos Trans R Soc Lond B Biol Sci, 356, 1013, 10.1098/rstb.2001.0890

International Agency for Research on Cancer, 1994

Ott, 2012, Global epidemiology of hepatitis B virus infection: new estimates of age-specific HBsAg seroprevalence and endemicity, Vaccine, 30, 2212, 10.1016/j.vaccine.2011.12.116

Centers for Disease Control and Prevention. Hepatitis B. 2010. Available at: http://wwwnc.cdc.gov/travel/yellowbook/2010/chapter-2/hepatitis-b.aspx. Accessed November 5, 2014.

Marinier, 1985, Lack of perinatal transmission of hepatitis B virus infection in Senegal, West Africa, J Pediatr, 106, 843, 10.1016/S0022-3476(85)80371-1

Ming, 2002, Dominant role of hepatitis B virus and cofactor role of aflatoxin in hepatocarcinogenesis in Qidong, China, Hepatology, 36, 1214, 10.1053/jhep.2002.36366

Chen, 2006, Past HBV viral load as predictor of mortality and morbidity from HCC and chronic liver disease in a prospective study, Am J Gastroenterol, 101, 1797, 10.1111/j.1572-0241.2006.00647.x

Chen, 2009, Hepatitis B virus DNA levels and outcomes in chronic hepatitis B, Hepatology, 49, S72, 10.1002/hep.22884

McMahon, 2009, The natural history of chronic hepatitis B virus infection, Hepatology, 49, S45, 10.1002/hep.22898

McMahon, 2010, Natural history of chronic hepatitis B, Clin Liver Dis, 14, 381, 10.1016/j.cld.2010.05.007

Sumi, 2003, Influence of hepatitis B virus genotypes on the progression of chronic type B liver disease, Hepatology, 37, 19, 10.1053/jhep.2003.50036

World Health Organization. Hepatitis B. 2010. Available at: http://www.who.int/immunization/topics/hepatits_b/en/index.html. Accessed November 3, 2014.

Goldstein, 2005, A mathematical model to estimate global hepatitis B disease burden and vaccination impact, Int J Epidemiol, 34, 1329, 10.1093/ije/dyi206

World Health Organization, 2014

Filippelli, 2014, Hepatitis B vaccine by intradermal route in non responder patients: an update, World J Gastroenterol, 20, 10383, 10.3748/wjg.v20.i30.10383

Chang, 2009, Decreased incidence of hepatocellular carcinoma in hepatitis B vaccinees: a 20-year follow-up study, J Natl Cancer Inst, 101, 1348, 10.1093/jnci/djp288

Chiang, 2013, Thirty-year outcomes of the national hepatitis B immunization program in Taiwan, JAMA, 310, 974, 10.1001/jama.2013.276701

Liang, 2009, Evaluation of the impact of hepatitis B vaccination among children born during 1992-2005 in China, J Infect Dis, 200, 39, 10.1086/599332

Ang, 2013, Seroepidemiology of hepatitis B virus infection among adults in Singapore: a 12-year review, Vaccine, 32, 103, 10.1016/j.vaccine.2013.10.057

Yan, 2014, Viral entry of hepatitis B and D viruses and bile salts transportation share common molecular determinants on sodium taurocholate cotransporting polypeptide, J Virol, 88, 3273, 10.1128/JVI.03478-13

Ding, 2014, Cytidine deamination and cccDNA degradation: a new approach for curing HBV?, Hepatology, 60, 2118, 10.1002/hep.27386

Choo, 1989, Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome, Science, 244, 359, 10.1126/science.2523562

Simmonds, 2004, Genetic diversity and evolution of hepatitis C virus: 15 years on, J Gen Virol, 85, 3173, 10.1099/vir.0.80401-0

Simmonds, 1993, Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS-5 region, J Gen Virol, 74, 2391, 10.1099/0022-1317-74-11-2391

Pybus, 2009, Genetic history of hepatitis C virus in East Asia, J Virol, 83, 1071, 10.1128/JVI.01501-08

Pybus, 2007, Investigating the endemic transmission of the hepatitis C virus, Int J Parasitol, 37, 839, 10.1016/j.ijpara.2007.04.009

Bostan, 2010, An overview about hepatitis C: a devastating virus, Crit Rev Microbiol, 36, 91, 10.3109/10408410903357455

Tanaka, 2002, Inaugural Article: a comparison of the molecular clock of hepatitis C virus in the United States and Japan predicts that hepatocellular carcinoma incidence in the United States will increase over the next two decades, Proc Natl Acad Sci U S A, 99, 15584, 10.1073/pnas.242608099

Iida, 1999, Chronic Japanese schistosomiasis and hepatocellular carcinoma: ten years of follow-up in Yamanashi Prefecture, Japan, Bull World Health Organ, 77, 573

Frank, 2000, The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt, Lancet, 355, 887, 10.1016/S0140-6736(99)06527-7

Armstrong, 2000, The past incidence of hepatitis C virus infection: implications for the future burden of chronic liver disease in the United States, Hepatology, 31, 777, 10.1002/hep.510310332

Salomon, 2002, Empirically calibrated model of hepatitis C virus infection in the United States, Am J Epidemiol, 156, 761, 10.1093/aje/kwf100

Seeff, 2000, 45-year follow-up of hepatitis C virus infection in healthy young adults, Ann Intern Med, 132, 105, 10.7326/0003-4819-132-2-200001180-00003

Davis, 2010, Aging of hepatitis C virus (HCV)-infected persons in the United States: a multiple cohort model of HCV prevalence and disease progression, Gastroenterology, 138, 513, 10.1053/j.gastro.2009.09.067

Sofia, 2010, Discovery of a beta-d-2'-deoxy-2'-alpha-fluoro-2'-beta-C-methyluridine nucleotide prodrug (PSI-7977) for the treatment of hepatitis C virus, J Med Chem, 53, 7202, 10.1021/jm100863x

Sulkowski, 2014, Daclatasvir plus sofosbuvir for previously treated or untreated chronic HCV infection, N Engl J Med, 370, 211, 10.1056/NEJMoa1306218

IARC, 1987

Wild, 2000, Primary prevention of hepatocellular carcinoma in developing countries, Mutat Res, 462, 381, 10.1016/S1383-5742(00)00027-2

Plymoth, 2009, Control of hepatocellular carcinoma through hepatitis B vaccination in areas of high endemicity: perspectives for global liver cancer prevention, Cancer Lett, 286, 15, 10.1016/j.canlet.2009.08.024

Sun, 2002, Determinants of formation of aflatoxin-albumin adducts: a seven-township study in Taiwan, Br J Cancer, 87, 966, 10.1038/sj.bjc.6600584

Qian, 1994, A follow-up study of urinary markers of aflatoxin exposure and liver cancer risk in Shanghai, People's Republic of China, Cancer Epidemiol Biomarkers Prev, 3, 3

Ross, 1992, Urinary aflatoxin biomarkers and risk of hepatocellular carcinoma, Lancet, 339, 943, 10.1016/0140-6736(92)91528-G

Kuang, 2005, Hepatitis B 1762T/1764A mutations, hepatitis C infection, and codon 249 p53 mutations in hepatocellular carcinomas from Thailand, Cancer Epidemiol Biomarkers Prev, 14, 380, 10.1158/1055-9965.EPI-04-0380

Liu, 2010, Global burden of aflatoxin-induced hepatocellular carcinoma: a risk assessment, Environ Health Perspect, 118, 818, 10.1289/ehp.0901388

Wild, 2010, Mycotoxins and human disease: a largely ignored global health issue, Carcinogenesis, 31, 71, 10.1093/carcin/bgp264

Chen, 2013, Reduced aflatoxin exposure presages decline in liver cancer mortality in an endemic region of China, Cancer Prev Res (Phila), 6, 1038, 10.1158/1940-6207.CAPR-13-0168

London, 2006, Liver Cancer, 763

Donato, 2002, Alcohol and hepatocellular carcinoma: the effect of lifetime intake and hepatitis virus infections in men and women, Am J Epidemiol, 155, 323, 10.1093/aje/155.4.323

Kuper, 2000, Tobacco smoking, alcohol consumption and their interaction in the causation of hepatocellular carcinoma, Int J Cancer, 85, 498, 10.1002/(SICI)1097-0215(20000215)85:4<498::AID-IJC9>3.0.CO;2-F

Yuan, 2004, Synergism of alcohol, diabetes, and viral hepatitis on the risk of hepatocellular carcinoma in blacks and whites in the U.S., Cancer, 101, 1009, 10.1002/cncr.20427

International Agency for Research on Cancer, 1988

World Cancer Research Fund/American Institute for Cancer Research, 2007

Turati, 2014, Alcohol and liver cancer: a systematic review and meta-analysis of prospective studies, Ann Oncol, 25, 1526, 10.1093/annonc/mdu020

Alcorn, 2011, Mongolia's struggle with liver cancer, Lancet, 377, 1139, 10.1016/S0140-6736(11)60448-0

Chen, 2015, Effect of type 2 diabetes mellitus on the risk for hepatocellular carcinoma in chronic liver diseases: a meta-analysis of cohort studies, Eur J Cancer Prev, 24, 89, 10.1097/CEJ.0000000000000038

El-Serag, 2001, The role of diabetes in hepatocellular carcinoma: a case-control study among United States veterans, Am J Gastroenterol, 96, 2462, 10.1111/j.1572-0241.2001.04054.x

Wang, 2012, Increased risk of hepatocellular carcinoma in patients with diabetes mellitus: a systematic review and meta-analysis of cohort studies, Int J Cancer, 130, 1639, 10.1002/ijc.26165

Wang, 2012, Diabetes mellitus and risk of hepatocellular carcinoma: a systematic review and meta-analysis, Diabetes Metab Res Rev, 28, 109, 10.1002/dmrr.1291

Saunders, 2010, Systematic review: the association between obesity and hepatocellular carcinoma: epidemiological evidence, Aliment Pharmacol Ther, 31, 1051, 10.1111/j.1365-2036.2010.04271.x

Larsson, 2007, Overweight, obesity and risk of liver cancer: a meta-analysis of cohort studies, Br J Cancer, 97, 1005, 10.1038/sj.bjc.6603932

Jinjuvadia, 2014, The association between metabolic syndrome and hepatocellular carcinoma: systemic review and meta-analysis, J Clin Gastroenterol, 48, 172, 10.1097/MCG.0b013e3182a030c4

Shaw, 2010, Global estimates of the prevalence of diabetes for 2010 and 2030, Diabetes Res Clin Pract, 87, 4, 10.1016/j.diabres.2009.10.007

James, 2008, The epidemiology of obesity: the size of the problem, J Intern Med, 263, 336, 10.1111/j.1365-2796.2008.01922.x

IARC, 2004, Tobacco smoke and involuntary smoking, IARC Monogr Eval Carcinog Risks Hum, 83, 1

The health consequences of smoking: 50 years of progress. A report of the Surgeon General. Available at: http://www.surgeongeneral.gov/library/reports/50-years-of-progress/. Accessed December 10, 2014.

Lee, 2009, Meta-analysis of epidemiologic studies on cigarette smoking and liver cancer, Int J Epidemiol, 38, 1497, 10.1093/ije/dyp280

Bravi, 2013, Coffee reduces risk for hepatocellular carcinoma: an updated meta-analysis, Clin Gastroenterol Hepatol, 11, 1413, 10.1016/j.cgh.2013.04.039

Fon Sing, 2011, Epidemiological studies of the association between tea drinking and primary liver cancer: a meta-analysis, Eur J Cancer Prev, 20, 157, 10.1097/CEJ.0b013e3283447497

Bamia, 2014, Coffee, tea and decaffeinated coffee in relation to hepatocellular carcinoma in a European population: multicentre, prospective cohort study, Int J Cancer

Setiawan, 2014, Association of coffee intake with reduced incidence of liver cancer and death from chronic liver disease in the US multiethnic cohort, Gastroenterology, 148, 118, 10.1053/j.gastro.2014.10.005

Cavin, 2002, Cafestol and kahweol, two coffee specific diterpenes with anticarcinogenic activity, Food Chem Toxicol, 40, 1155, 10.1016/S0278-6915(02)00029-7

Muriel, 2010, Coffee and liver diseases, Fitoterapia, 81, 297, 10.1016/j.fitote.2009.10.003

Boettler, 2011, Coffee constituents as modulators of Nrf2 nuclear translocation and ARE (EpRE)-dependent gene expression, J Nutr Biochem, 22, 426, 10.1016/j.jnutbio.2010.03.011

Ludwig, 2014, Coffee: biochemistry and potential impact on health, Food Funct, 5, 1695, 10.1039/C4FO00042K

Yang, 2009, Cancer prevention by tea: animal studies, molecular mechanisms and human relevance, Nat Rev Cancer, 9, 429, 10.1038/nrc2641

Baigent, 2010, Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials, Lancet, 376, 1670, 10.1016/S0140-6736(10)61350-5

Chan, 2003, The statins as anticancer agents, Clin Cancer Res, 9, 10

Gazzerro, 2012, Pharmacological actions of statins: a critical appraisal in the management of cancer, Pharmacol Rev, 64, 102, 10.1124/pr.111.004994

Chiu, 2011, Statin use and the risk of liver cancer: a population-based case-control study, Am J Gastroenterol, 106, 894, 10.1038/ajg.2010.475

Lai, 2013, Statin use and risk of hepatocellular carcinoma, Eur J Epidemiol, 28, 485, 10.1007/s10654-013-9806-y

Leung, 2013, Common cancer risk and statins: a population-based case-control study in a Chinese population, Expert Opin Drug Saf, 12, 19, 10.1517/14740338.2013.744392

Tsan, 2013, Statins and the risk of hepatocellular carcinoma in patients with hepatitis C virus infection, J Clin Oncol, 31, 1514, 10.1200/JCO.2012.44.6831

Tsan, 2012, Statins and the risk of hepatocellular carcinoma in patients with hepatitis B virus infection, J Clin Oncol, 30, 623, 10.1200/JCO.2011.36.0917

Friis, 2005, Cancer risk among statin users: a population-based cohort study, Int J Cancer, 114, 643, 10.1002/ijc.20758

Marelli, 2011, Statins and risk of cancer: a retrospective cohort analysis of 45,857 matched pairs from an electronic medical records database of 11 million adult Americans, J Am Coll Cardiol, 58, 530, 10.1016/j.jacc.2011.04.015

El-Serag, 2009, Statins are associated with a reduced risk of hepatocellular carcinoma in a large cohort of patients with diabetes, Gastroenterology, 136, 1601, 10.1053/j.gastro.2009.01.053

Khurana, 2005, Statins are protective against hepatocellular cancer in patients with hepatitis C virus infection: half a million U.S. veterans' study, Gastroenterology, 128, A714

Friedman, 2008, Screening statins for possible carcinogenic risk: up to 9 years of follow-up of 361,859 recipients, Pharmacoepidemiol Drug Saf, 17, 27, 10.1002/pds.1507

McGlynn, 2014, Statin use and risk of hepatocellular carcinoma in a U.S. population, Cancer Epidemiol, 38, 523, 10.1016/j.canep.2014.06.009

Bjorkhem-Bergman, 2014, Statin treatment reduces the risk of hepatocellular carcinoma but not colon cancer-results from a nationwide case-control study in Sweden, Pharmacoepidemiol Drug Saf, 23, 1101, 10.1002/pds.3685

Pradelli, 2012, Statins and primary liver cancer: a meta-analysis of observational studies, Eur J Cancer Prev, 22, 229, 10.1097/CEJ.0b013e328358761a

Singh, 2013, Statins are associated with a reduced risk of hepatocellular cancer: a systematic review and meta-analysis, Gastroenterology, 144, 323, 10.1053/j.gastro.2012.10.005

Franciosi, 2013, Metformin therapy and risk of cancer in patients with type 2 diabetes: systematic review, PLoS one, 8, e71583, 10.1371/journal.pone.0071583

Singh, 2013, Anti-diabetic medications and risk of pancreatic cancer in patients with diabetes mellitus: a systematic review and meta-analysis, Am J Gastroenterol, 108, 510, 10.1038/ajg.2013.7

Zhang, 2013, Metformin and reduced risk of hepatocellular carcinoma in diabetic patients: a meta-analysis, Scand J Gastroenterol, 48, 78, 10.3109/00365521.2012.719926

Hagberg, 2014, Anti-diabetic medications and risk of primary liver cancer in persons with type II diabetes, Br J Cancer, 111, 1710, 10.1038/bjc.2014.447

Conaghan, 2012, A turbulent decade for NSAIDs: update on current concepts of classification, epidemiology, comparative efficacy, and toxicity, Rheumatol Int, 32, 1491, 10.1007/s00296-011-2263-6

Cervello, 2005, Correlation between expression of cyclooxygenase-2 and the presence of inflammatory cells in human primary hepatocellular carcinoma: possible role in tumor promotion and angiogenesis, World J Gastroenterol, 11, 4638, 10.3748/wjg.v11.i30.4638

Fodera, 2004, Induction of apoptosis and inhibition of cell growth in human hepatocellular carcinoma cells by COX-2 inhibitors, Ann N Y Acad Sci, 1028, 440, 10.1196/annals.1322.052

Leng, 2003, Cyclooxygenase-2 promotes hepatocellular carcinoma cell growth through Akt activation: evidence for Akt inhibition in celecoxib-induced apoptosis, Hepatology, 38, 756, 10.1053/jhep.2003.50380

Cibere, 1997, Rheumatoid arthritis and the risk of malignancy, Arthritis Rheum, 40, 1580, 10.1002/art.1780400906

Coogan, 2000, Nonsteroidal anti-inflammatory drugs and risk of digestive cancers at sites other than the large bowel, Cancer Epidemiol Biomarkers Prev, 9, 119

Sahasrabuddhe, 2012, Nonsteroidal anti-inflammatory drug use, chronic liver disease, and hepatocellular carcinoma, J Natl Cancer Inst, 104, 1808, 10.1093/jnci/djs452

Knights, 2010, Defining the COX inhibitor selectivity of NSAIDs: implications for understanding toxicity, Expert Rev Clin Pharmacol, 3, 769, 10.1586/ecp.10.120

Jankowska, 2010, Aspirin chemoprevention of gastrointestinal cancer in the next decade. a review of the evidence, Pol Arch Med Wewn, 120, 407

Kern, 2002, Proapoptotic and antiproliferative potential of selective cyclooxygenase-2 inhibitors in human liver tumor cells, Hepatology, 36, 885, 10.1053/jhep.2002.36125

Imaeda, 2009, Acetaminophen-induced hepatotoxicity in mice is dependent on Tlr9 and the Nalp3 inflammasome, J Clin Invest, 119, 305